SAN CARLOS, Calif., Oct. 19 /PRNewswire-FirstCall/ -- Nuvelo, Inc. , today announced that it will hold a conference call to discuss its third quarter 2005 financial results and accomplishments on Tuesday, November 1, 2005, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time).
To participate in the conference call, please dial 800-510-0146 for domestic callers and 617-614-3449 for international callers and reference conference passcode, 19105503. A telephone replay of the conference call will be available through Tuesday, November 15, 2005. To access the replay, please dial 888-286-8010 for domestic callers and 617-801-6888 for international callers and reference conference passcode, 94413845.
In addition, this call is being webcast by Thomson/CCBN and can be accessed at Nuvelo’s website at www.nuvelo.com.
The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com, Thomson’s individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (www.streetevents.com), a password-protected event management site.
About Nuvelo
Nuvelo, Inc. is dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular and cancer therapy. Nuvelo’s clinical pipeline includes alfimeprase, a direct acting thrombolytic in Phase 3 trials for the treatment of acute peripheral arterial occlusion (PAO) and catheter occlusion and rNAPc2, an anticoagulant currently in Phase 2 trials that inhibits the factor VIIa and tissue factor complex. Nuvelo recently identified NU206 as a preclinical development candidate from its proprietary research programs and expects to leverage expertise in secreted proteins and antibody discovery to expand its pipeline and create partnering and licensing opportunities.
Information about Nuvelo is available at our website at www.nuvelo.com or by phoning 650-517-8000.
Nuvelo, Inc.
CONTACT: Nicole Estrin of Nuvelo, Inc., +1-650-517-8472, ornestrin@nuvelo.com
